Innovation

FDA Approves Promising New Alzheimer’s Drug Leqembi

BIG STEPS

It is the first Alzheimer’s antibody treatment to get full FDA approval and to be broadly covered by Medicare.

Erik Uebelacker
Erik Uebelacker
Alzheimer's drug Leqembi was approved by the FDA Thursday, the same day that Medicare pledged to cover it.
EISAI/Handout via REUTERS / Reuters
Erik Uebelacker

Erik Uebelacker

Uebey

Got a tip? Send it to The Daily Beast here.

Trending Now
Crime & JusticeDiddy Shocks Courtroom With Gray Hair and Beard
Eboni Boykin-Patterson
Crime & JusticeMissing College Student’s Final Venmo Payments Revealed
Nandika Chatterjee
PoliticsNew Proposed Trump Travel Ban Would Target 43 Countries
Catherine Bouris
U.S. NewsTrump Press Sec Backs Out of WH Correspondents’ Dinner Roast
Kenneal Patterson
U.S. NewsStarbucks Must Pay $50M After Spill Burns Man’s Genitals
Kenneal Patterson